Introduction
The death adder (Acanthophis sp.) (Figures 1 and 2) species exists in PNG.1 Early work by Kellaway demonstrated a curare-like activity of the venom in is the most widely distributed venomous snake in Papua New Guinea (PNG). It is found throughout rabbits and cats.2 Subsequently, a number of venom components have been characterized, including four the mainland coastal regions of PNG and Irian Jaya, and at altitudes of up to 4000 ft in the Highlands. distinct neurotoxins which cause post-synaptic blockade in vitro. [3] [4] [5] [6] The action of the venom on the Death adders also occur throughout much of Australia and a number of eastern Indonesian islands coagulation system is less clear; anticoagulant, weak pro-coagulant and no pro-coagulant or anti-( Figure 3 ). The relationship of PNG death adders to Australian species is uncertain; originally designated coagulant activity have all been described. [7] [8] [9] [10] [11] [12] Fibrinolytic activity has not been demonstrated.9 as 'Acanthophis antarcticus', it now seems likely that Acanthophis praelongus and at least one other Australian case reports and a series reported by 
Campbell from Port Moresby have demonstrated that
Methods the major effect of envenoming in man is neurotoxicAll patients presenting with a history of snakebite to ity, which is sometimes dramatically responsive to Port Moresby General Hospital (PMGH) between antivenom.13, 14 We describe 32 envenomed patients March 1990 and June 1992 were studied prospectwith enzyme-immunoassay-proven death-adder bites studied over a two-year period.
ively. History and examination were recorded on standard forms. Blood was taken for haematological lished by assaying 105 control samples from Papua New Guineans who had never been bitten by snakes. and biochemical investigations and 2 ml of whole blood was placed in a new, clean, dry, glass tube Death adder bite was diagnosed when a significant concentration (greater than mean+2SD of control for determination of the 20 min whole blood clotting test (20 WBCT).15,16 Blood (9 ml) was added to 1 ml OD values) of Acanthophis sp. venom antigen alone was detected in one or more of the samples from tri-sodium citrate (3.8%), immediately centrifuged, separated and frozen in 1.5 ml aliquots at -70°C for each patient. measurement of clotting factors, which were assayed as previously described.17 Serum and urine samples, Effects of Acanthophis sp. venom on blood and bite wound swabs and aspirates were frozen at coagulation.
-70°C for venom detection. Urine was examined by microscopy and tested by dipstick.
Increasing amounts of pooled Papua New Guinea death adder venom from Central Province, Madang Patients with signs of envenoming (lymph node tenderness or neurotoxicity) were treated with one and Karkar Island (1.25-20 mg) were added to 1 ml whole human blood in glass tubes. Tubes were ampoule of polyspecific antivenom (Commonwealth Serum Laboratories, Melbourne) diluted to a total incubated at 37°C, and clot formation was observed at 1 min intervals. Venom was added to human volume of 100 ml and infused intravenously over 20 min. Promethazine (12.5 or 25 mg intravenously) plasma at increasing concentrations (1.25-10 mg/ml) and the prothrombin time (PT) and activated partial was given before antivenom as prophylaxis against reactions. Patients were examined at least six-hourly thromboplastin time (APTT) of the mixtures were recorded. Fibrinogenase (fibrinogenolytic) activity for the first 36 h and daily thereafter.
was investigated by the addition of venom (2.5-20 mg/ml) to a 2 mg/ml human fibrinogen (Kabi)
Venom detection
solution. The mixture was incubated for 37°C for Samples were tested with antisera against the venoms 15 min, the reaction stopped with 5 mM EDTA, and of the five important species of venomous snake the mixture analysed by SDS-PAGE in a 12% gel found in PNG: taipan (Oxyuranus scutellatus canni), under reducing conditions.21 Papuan black snake (Pseudechis papuanus), death adder (Acanthophis sp.), common brown snake
Statistical methods
(Pseudonaja textilis) and New Guinean small-eyed snake (Micropechis ikaheka) in an enzyme immunoPlatelet counts and clotting factor measurements were compared between patients and controls using assay (EIA).18-20 Background absorbence was estab- Eighteen patients had signs of envenoming. Lymph node pain and drooping of the eyelids were the most of neurotoxicity could be rapid; one patient presented common symptoms on admission; one patient comwith a respiratory arrest 2 h after the bite and needed plained of transient bleeding from the mouth, immediate intubation. Five patients (27.7%) required although this was not confirmed by clinical examinaintubation and ventilation at a median time of 13 h tion (Table 1) . Symptoms were reported as early as (range 2-23.5) after the bite. Bleeding was not 5 min after the bite; neurological symptoms were observed in any patient on admission, and all had experienced between 1 and 13 (median 3.5) h after normally clotting blood using the 20WBCT. All the bite. Neither local swelling nor other signs were patients survived. seen at the bite site. Seventeen patients (94.4%) had
Thirteen patients were treated with antivenom; neurotoxicity; signs were present by the time of two received more than one ampoule, because of admission in all ( Table 2 ). The severity of neurotoxicinitial inappropriate treatment with taipan antivenom ity varied from mild ptosis to complete respiratory in one and uncertainty about the biting species in paralysis requiring ventilation ( Figure 4 ). Progression the other. One patient was treated with edrophonium as a diagnostic test and another was treated with neostigmine in addition to antivenom. The response ophthalmoplegia, bulbar weakness and severe ptosis aspiration. Another was referred from Western Province 5 days after the bite because of renal had resolved. Three other patients treated 18, 24 and 43 h after the bite showed no obvious response failure; the patient had a creatinine level of 1790 mmol/l on admission but was not fluidto antivenom; a complete ophthalmoplegia persisted for almost 48 h after antivenom in one and another overloaded or hypercatabolic. There was no clinical indication of serum sickness. Renal function required intubation for 70 h and had ptosis and an ophthalmoplegia which persisted for 72 h after antirecovered fully with conservative treatment. An electrocardiogram demonstrated second-degree atriovenom. The response of neurotoxicity to antivenom could not be assessed in seven other treated patients, ventricular block with a ventricular rate of 36 bpm which persisted throughout recovery. Although this because of only mild neurotoxicity in three, initial treatment at health centres in two, delayed diagnosis rhythm could have pre-dated the snakebite, the observation of a pulse rate of 100 bpm on admission in one child and inadequate follow-up observations in one patient.
to the peripheral hospital suggests that the dysrhythmia was caused by the snakebite. Five patients did not receive antivenom; treatment was withheld in three patients with minor neurological signs and two patients presented late with stable neurotoxic signs. One who presented
Illustrative case reports
with marked ptosis and a partial ophthalmoplegia
Patient S1492
18 h after the bite had normal eye movements and only mild ptosis 36 h after the bite. The other had A seven-year-old girl was bitten on the right instep by a 34-cm-long death adder ( Figure 5 ) close to a ptosis and partial ophthalmoplegia which persisted for over 72 h after the bite.
stream where she had been drinking. The snake was killed, and she was taken to a local health centre Complications were rare. One patient developed pulmonary consolidation, probably secondary to where a compression bandage was applied. When she arrived at the hospital, 3.5 h after the bite, she of his eyelids. On arrival at hospital 12 h after the bite, two small fang marks were visible and he had was complaining of pain in the right groin and had been vomiting. Symptoms of neurotoxicity, heavy tender enlarged lymph nodes in the groin. He had moderate ptosis, an almost complete ophthalmopleeyelids and difficulty in swallowing, had started about an hour and a half after the bite and she was gia, marked dysarthria and jaw opening was restricted (interdental distance 12 mm). His breathing was very beginning to have difficulty in breathing. On examination, there was tenderness but no swelling over shallow and he was unable to swallow his secretions. The whole blood clotting test was nortwo fang marks and she had tender lymph nodes in the groin. She had moderate ptosis, a partial ophthalmal. Intravenous edrophonium (10 mg) and atropine (0.6 mg) were given and there was a transient moplegia, and had developed pooling of secretions because of difficulty in swallowing. Respiratory increase in the duration of upward gaze from 5 to 15 s five minutes later. One ampoule of death adder efforts were weak and involved the diaphragm only. The whole blood clotting time was normal. She was antivenom was infused intravenously and the patient was intubated. Within 30 min of antivenom, there immediately intubated and ventilated by hand. One ampoule of death adder antivenom was infused over appeared to be an improvement in the strength of his respiration, and there was a marked improvement 20 min, and she was given 0.45 mg neostigmine and 0.6 mg atropine intravenously. Over the followin peripheral grip strength. The patient was able to extubate himself. Six hours after antivenom, he was ing 2 h, there was a distinct improvement in the level of respiratory effort and the patient was extubbreathing adequately spontaneously, but still had marked ptosis and an almost complete ophthalmoated. Mild ptosis persisted, but 14 h after admission to hospital, all signs of neurotoxicity had disappeared plegia. Eighteen hours after antivenom, there was very mild ptosis, but no other evidence of neurotoxicand the patient made an uneventful recovery. ity; interdental distance was now 40 mm. The patient
Patient 0492
made a full and uneventful recovery. A 30-year-old man was bitten by an unseen snake on the right foot whilst urinating at night close to Laboratory studies his house. On waking, he had noticed slight pain in his foot, right groin and abdomen and had vomited.
Fourteen patients had laboratory investigations. The mean admission haemoglobin level was 12.5 g/dl. He had also noted slurring of speech and drooping White cell counts were slightly elevated in two patients on admission, and rose in three patients to peak counts of 16.5, 16.8 and 22.5×106/l in the absence of any other obvious cause. The mean admission platelet count (prior to antivenom) of 135.8×109/l was significantly reduced compared to controls (difference between means 89.9×109/l, 95% CIs for difference 44.7-135×109/l, p=0.0001); platelet counts remained low for several days. Urea and electrolyte levels were normal in all but the one patient mentioned above. Creatine kinase (CK) levels were significantly elevated (prior to any intramuscular injection) in 8/12 patients on admission (median 411, range 164-4220 IU/l) and rose further in most patients during admission (median peak 548 IU/l).
Blood coagulation studies were done on admis- Figure 6 . SDS-PAGE of fibrogen treated with Acanthophis sion in 13 patients ( in whom repeated measurements were made between 36 h and 13 days after antivenom, there were significant reductions in PT and PTTK ( p= 11% of envenomed patients presenting to hospital.20 Although it is primarily nocturnal, we, like Campbell, 0.0006 and p=0.036, respectively) and a nonsignificant elevation in fibrinogen levels ( p=0. 17) found that many victims were not bitten at night; this may be the result of snakes sleeping on warm after treatment. Clotting factor levels measured in one patient did not demonstrate a marked depletion paths during the day.13,22 Immunoassay data in envenomed and non-envenomed patients (not in any of the coagulation factors or inhibitors (Table 4) .
shown) suggest that envenoming is less common after death adder bites than after bites by the more The addition of Acanthophis sp. venom to whole human blood prevented clot formation at levels in common taipan; the 50% mortality rate in untreated death adder bites that was quoted in the early part excess of 5 mg/ml. The venom had no coagulant effect on plasma. Both PT and APTT were prolonged of this century was clearly an overestimate. 23 The death adder appears to cause less severe envenoming in the presence of venom at a concentration of 1.25 mg/ml, although mixtures continued to clot up than the taipan. Campbell described 15 cases bitten by death adders, eight identified by the dead snake to the maximum venom concentration tested (10 mg/ml). No fibrinogenolytic activity could be and the rest by his patients' description of the snake. 13 Only three of these patients demonstrated demonstrated (Figure 6 ). neurotoxic signs, seven had tender lymphadenopathy
Venom antigen detection
alone and five were not envenomed. In our envenomed patients, signs of neurotoxicity were Venom antigen was detected in the serum of 16 found in all but one, but these were usually mild. envenomed patients (88.8%) in concentrations from Only five patients (27.1%) developed severe neuro-7.8 to 5000 (median 48) ng/ml; the diagnosis was toxicity requiring intubation; in contrast 41.7% of made by detection in the urine and in a wound taipan victims seen over the same period required swab in two patients. Three of 9 (33.3%) urines intubation.24 examined were positive for venom antigen; all three
The clinical picture of neurotoxicity was similar aspirates tested and two of six swabs tested were to that described in envenoming by other positive. Serum levels in 14 patients with no clinical Australasian elapids.25 However, the administration evidence of envenoming ranged from 10 to 420 of antivenom appeared to be much more effective (median 24) ng/ml. than in patients bitten by taipans and Papuan black snakes.20,24 Neurotoxicity did not progress after antiDiscussion venom in any patient, in contrast to the progression which occurs in 37% of patients bitten by the The death adder is the second most common cause of envenoming in the Central Province and National taipan.24 None of the five patients who required intubation had been treated previously with antiCapital District of PNG, accounting for approximately detected clinically in our patients, but CK levels were elevated in most of them, indicating that the venom. In addition, antivenom appeared to have an venom has some myotoxic activity in vivo. This is almost immediate effect in three of the six patients at odds with the reported lack of myotoxic activity in whom a response could be properly evaluated.
of Australian death adder venom in monkeys and This is consistent with Campbell's observation that mice,11,32 although some samples of A. antarcticus paralysis was 'rapidly and completely reversed' in venom do contain phospholipase A activity.10,33
In contrast to results of our studies of envenoming three patients given large amounts of antivenom by other PNG species, improvement in the manage-(equivalent to 3-8 ampoules of death adder antiment of death adder bites is more likely to be venom). 13 The apparent efficacy of the antivenom is achieved by the rational use of anticholinesterases likely to be related to the predominantly postthan by improving the efficacy of antivenom. The synaptic site of action of death adder neurotoxins.
response to edrophonium in one patient, a definite Animal experiments show that some postimprovement in hand grip and degree of ptosis, was synaptically-acting toxins, such as that of Naja nigriimpressive, in contrast to ten taipan patients who collis, can be displaced from the binding site, preshowed no improvement in a double-blind study of venting blockade of the post-synaptic acetylcholine edrophonium (D.G. Lalloo, A.J. Trevett, unpublished receptor,26 and good responses to antivenom have observations). The small numbers, sporadic admisbeen noted in envenoming with other predominantly sions and difficulty in the rapid identification of post-synaptically-acting toxins.27 death adder cases precluded a formal trial of the Abnormal blood coagulation results have not effect of anticholinesterases. However, animal studbeen reported previously in human death adder ies, published case reports and frequent clinical envenoming, but prolongation of the prothrombin anecdotes suggest that anticholinesterases may be as time was noted in experimental envenoming of effective in death adder envenoming as they are in monkeys.11 Previous in vitro testing of the venom Asian cobra envenoming.34-38 The rapid improvehas been inconclusive. [7] [8] [9] [10] [11] 28 The finding of slightly ment in the one patient in this study given both altered clotting times in patients is supported by antivenom and neostigmine suggests that, in addition our detection of anticoagulant activity in venom to effective first aid and prompt treatment, the of Acanthophis sp. from Papua New Guinea.
optimal management of death adder envenoming Anticoagulant activity could be due to a phospholipmay require both antivenom and anticholinesterases. ase A 2 similar to that detected recently in the venom of the Papuan Black snake (Pseudechis papuanus).29
